Skip to main content
. 2012 Oct 18;8(2):265–270. doi: 10.2215/CJN.01000112

Table 3.

Variables associated with withdrawal from dialysis for all patients and per age group

Variable Hazard Ratio (95% CI)
All Patients Patients Age < 75 yr Patients Age ≥ 75 yr
Demographic
 Age (10-yr increments) 1.81 (1.75–1.88) 1.80 (1.69–1.91) 1.92 (1.72–1.15)
  Male versus female 0.85 (0.79–0.92) 0.89 (0.81–0.97) 0.83 (0.75–0.93)
Race 1.00 1.00 1.00
  White (reference)
  Black 0.31 (0.22–0.44) 0.29 (0.19–0.43) 0.37 (0.24–0.56)
  Asian 0.38 (0.28–0.51) 0.42 (0.29–0.59) 0.36 (0.25–0.51)
  Native Canadian 0.76 (0.59–0.99) 0.87 (0.63–1.20) 0.58 (0.35–0.97)
 Weight 1.00 1.00 1.00
  Normal (BMI > 18.5–24.9 kg/m2)
  Underweight (BMI < 18.5 kg/m2) 1.37 (1.16–1.61) 1.45 (1.12–1.86) 1.30 (1.05–1.62)
  Overweight (BMI, 25–29.9 kg/m2) 0.92 (0.83–1.02) 0.90 (0.78–1.05) 0.93 (0.82–1.06)
  Obese (BMI ≥ 30 kg/m2) 0.93 (0.84–1.03) 0.93 (0.81–1.07) 093 (0.81–1.0)
 Urban versus rural dewller 0.89 (0.80–1.00) 0.97 (0.82–1.14) 0.82 (0.73–0.93)
 Income quintile 1.00 1.00 1.0
  1 (lowest) (reference)
   2 0.98 (0.88–1.10 1.00 (0.87–1.17) 0.97 (0.84–1.12)
   3 0.90 (0.80–1.01) 0.96 (0.81–1.14) 0.84 (0.71–0.99)
   4 0.91 (0.80–1.04) 0.92 (0.77–1.12) 0.89 (0.75–1.06)
   5 0.94 (0.84–1.05) 0.98 (0.84–1.14) 0.91 (0.76–1.09)
 Hemodialysis versus peritoneal dialysis 1.09 (0.79,1.50) 1.13 (0.71–1.80) 1.01 (0.58–1.75)
 Home versus in-center hemodialysis 0.78 (0.56–1.09) 0.80 (0.48–1.33) 0.75 (0.45–1.24)
 Community center versus hospital 0.50 (0.26–0.94) 0.52 (0.19–1.42) 0.46 (0.20–1.06)
Laboratory values
 Hemoglobin (g/dl) 1.00 (0.97–1.02) 0.99 (0.96–1.02) 1.01 (0.97–1.04)
 Albumin (g/L) 0.86 (0.80–0.92) 0.83 (0.74–0.92) 0.90 (0.81–0.99)
Timing
 Early versus late initiationa 1.17 (1.06–1.30) 1.17(1.03,1.32) 1.16 (1.03–1.32)
 Late versus early referralb 1.27 (1.16–1.39) 1.30 (1.15–1.47) 1.23 (1.09–1.38)
 Era: dialysis initiation 2006–2009 versus 2001–2005 1.15 (1.02–1.30) 1.18 (1.02,1.36) 1.13 (0.97–1.31)
ESRD primary diagnosis
 GN (reference) 1.0 1.0 1.0
 Diabetes 1.58 (1.37–1.82) 1.86 (1.50–2.32) 1.31 (1.10–1.57)
 Renovascular 1.26 (1.06–1.49) 1.43 (1.12–1.82) 1.07 (0.86–1.32)
 Other 1.46 (1.23–1.72) 1.68 (1.32–2.14) 1.25 (1.00–1.57)
Comorbid conditions
 Coronary artery disease 1.04 (0.96–1.12) 1.04 (0.93–1.17) 1.03 (0.94–1.13)
 Peripheral vascular disease 1.19 (1.08–1.31) 1.26 (1.11–1.42) 1.13 (0.99–1.30)
 Diabetes 1.15 (1.02–1.31) 1.15 (0.94–1.40) 1.15 (0.98–1.36)
 Hypertension 0.75 (0.67–0.85) 0.73 (0.64–0.84) 0.78 (0.68–0.91)
 Congestive heart failure 0.97 (0.87–1.08) 1.01 (0.87–1.17) 0.94 (0.81–1.08)
 Cerebrovascular disease 1.30 (1.21–1.41) 1.39(1.22,1.59) 1.24(1.11,1.37)
 Lung disease 1.04 (0.9–1.18) 1.04 (0.88–1.23) 1.04 (0.89–1.21)
 Malignancy 1.62 (1.47–1.78) 2.01 (1.75–2.30) 1.35 (1.19–1.54)
Provinces (compared with Canada)
 Ontario 1.15 (0.96–1.38) 1.18 (0.96,1.46) 1.11 (0.93–1.33)
 Alberta 0.41 (0.19–0.86) 0.39 (0.17–0.90) 0.42 (0.21–0.86)
 British Columbia 0.88 (0.74–1.05) 0.86(0.67–1.09) 0.91 (0.74–1.11)
 Manitoba 1.21 (1.01–1.44) 1.17 (1.00–1.37) 1.28 (0.96–1.71)
 New Brunswick 0.76 (0.61–0.94) 0.72 (0.51–1.03) 0.69 (0.52–0.92)
 Newfoundland 1.19 (1.02–1.40) 0.98 (0.61–1.56) 1.44 (1.18–1.76)
 Nova Scotia 1.67 (1.40–2.00) 1.84 (1.54–2.20) 1.53 (1.18–1.98)
 Quebec 1.31 (1.05–1.62) 1.45 (1.13–1.86) 1.16 (0.92–1.46)
 Saskatchewan 1.01 (0.96–1.38) 0.96 (0.75–1.25) 1.04 (0.71–1.51)

CI, confidence interval; BMI, body mass index.

a

Early initiation defined as estimated GFR > 10.5 ml/min per 1.73 m2; late initiation defined as estimated GFR ≤ 10.5 ml/min per 1.73 m2.

b

Late referral defined as first seen by a nephrologist <90 days before initiation of dialysis.